Want to see KR:002630 full AI Analyst Report?
ORIENTBIO, Inc. (002630) Income Statement
ORIENTBIO, Inc. Income Statement
Last quarter (Q1 2026), ORIENTBIO, Inc.'s total revenue was $6.59B, a decrease of 14.19% from the same quarter last year. In Q1, ORIENTBIO, Inc.'s net income was $4.85B. See ORIENTBIO, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 29.75B | $ 29.40B | $ 28.01B | $ 28.82B | $ 26.28B | |
| $ 3.96B | $ 7.20B | $ 9.58B | $ 9.82B | $ 9.01B | |
| $ 8.40B | $ 10.27B | $ 10.23B | $ 8.37B | $ 12.79B | |
| Depreciation and Amortization | $ 2.20B | $ 1.95B | $ 2.68B | $ 3.09B | $ 3.93B |
| $ -2.24B | $ -11.02B | $ 15.67B | $ -9.25B | $ 997.25M | |
| $ -4.44B | $ -3.08B | $ -645.95M | $ 1.45B | $ -3.78B | |
| $ -125.19M | $ -10.12B | $ 13.52B | $ -14.04B | $ 419.55M | |
| $ -4.57B | $ -13.19B | $ 12.87B | $ -12.59B | $ -3.36B | |
| $ -4.57B | $ -13.19B | $ 12.87B | $ -12.42B | $ 34.20B | |
| Per Share Metrics | |||||
| Basic EPS | $ -154.06 | $ -445.14 | $ 434.22 | $ -419.12 | $ -52.58 |
| Diluted EPS | $ -154.06 | $ -445.14 | $ 434.22 | $ -419.12 | $ -52.58 |
| Weighted Average Shares Outstanding | 29.64M | 29.64M | 29.64M | 29.64M | 29.65M |
| Weighted Average Shares Outstanding (Diluted) | 29.64M | 29.64M | 29.64M | 29.64M | 29.65M |
Currency in KRW
